External validation of the pretreatment nomogram to predict acute urinary retention after 125I prostate brachytherapy

Brachytherapy

Volumn 11, Issue 4, 2012, Pages 256-264

  Roeloffzen, Ellen M ^a   Crook, Juanita ^b   Monninkhof, Evelyn M ^a   McLean, Michael ^c   van Vulpen, Marco ^a   Saibishkumar, Elantholi P ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute urinary retention; External validation; Predictive nomogram; Prostate brachytherapy; Prostate cancer

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CALIBRATION; CANCER ADJUVANT THERAPY; CANCER STAGING; CONTROLLED STUDY; DOSIMETRY; EXTERNAL VALIDITY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NOMOGRAM; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; URINE RETENTION;

ADULT; AGED; ALGORITHMS; BRACHYTHERAPY; COMORBIDITY; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NETHERLANDS; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URINARY RETENTION;

EID: 84862514868     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.12.011     Document Type: Article

References (28)

1. Terk M.D., Stock R.G., Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998, 160:1379-1382.
2. Lee N., Wuu C.S., Brody R., et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2000, 48:1457-1460.
3. Bucci J., Morris W.J., Keyes M., et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002, 53:91-98.
4. Crook J., McLean M., Catton C., et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 2002, 52:453-460.
5. Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study. Int J Radiat Oncol Biol Phys 2002, 52:712-719.
6. Roeloffzen E.M., Hinnen K.A., Battermann J.J., et al. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life. Int J Radiat Oncol Biol Phys 2010, 77:1322-1328.
7. Crook J., Fleshner N., Roberts C., et al. Long-term urinary sequelae following 125iodine prostate brachytherapy. J Urol 2008, 179:141-145.
8. Roeloffzen E.M., Vulpen van M., Battermann J.J., et al. Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 2011, 81:737-744.
9. Vergouwe Y., Steyerberg E.W., Eijkemans M.J., et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol 2005, 58:475-483.
10. Toll D.B., Janssen K.J., Vergouwe Y., et al. Validation, updating and impact of clinical prediction rules: A review. J Clin Epidemiol 2008, 61:1085-1094.
11. Royston P., Moons K.G., Altman D.G., et al. Prognosis and prognostic research: Developing a prognostic model. BMJ 2009, 338:b604.
12. Villeirs G.M., De Meerleer G.O. Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. Eur J Radiol 2007, 63:361-368.
13. Roeloffzen E.M., Monninkhof E.M., Battermann J.J., et al. Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate. Int J Radiat Oncol Biol Phys 2010, 80:76-84.
14. Ash D., Flynn A., Battermann J., et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000, 57:315-321.
15. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 44:789-799.
16. Battermann J.J., Boon T.A., Moerland M.A. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 2004, 71:23-28.
17. Crook J., Toi A., McLean M., Pond G. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy. Brachytherapy 2002, 1:131-137.
18. Trotti A. The evolution and application of toxicity criteria. Semin Radiat Oncol 2002, 12:1-3.
19. Vergouwe Y., Moons K.G., Steyerberg E.W. External validity of risk models: Use of benchmark values to disentangle a case-mix effect from incorrect coefficients. Am J Epidemiol 2010, 172:971-980.
20. Martens C., Pond G., Webster D., et al. Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy. Brachytherapy 2006, 5:9-13.
21. Ikeda T., Shinohara K. Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: our experience and literature review. Int J Urol 2009, 16:558-560.
22. Van den Bergh R.C., Vasarainen H., van der Poel H.G., et al. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study. BJU Int 2010, 105:956-962.
23. Klotz L., Zhang L., Lam A., et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2009, 28. 126-131.
24. Van den Bergh R.C., Essink-Bot L., Roobol M.J., et al. Do anxiety and distress increase during active surveillance for low risk prostate cancer?. J Urol 2010, 183:1786-1791.
25. Roeloffzen E.M., Battermann J.J., Van Deursen M.J., et al. The influence of dose on the risk of acute urinary retention after I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 2010, 80:76-84.
26. Taussky D., Austen L., Toi A., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 2005, 62:974-980.
27. Waterman F.M., Yue N., Corn B.W., et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 1998, 41:1069-1077.
28. Altman D.G., Royston P. What do we mean by validating a prognostic model?. Stat Med 2000, 19:453-473.